Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,300 | 10 | 26.7% |
| Honoraria | $17,000 | 12 | 26.3% |
| Consulting Fee | $13,068 | 12 | 20.2% |
| Food and Beverage | $11,627 | 405 | 18.0% |
| Travel and Lodging | $5,611 | 23 | 8.7% |
| Education | $75.06 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $19,651 | 58 | $0 (2023) |
| Shire North American Group Inc | $11,240 | 27 | $0 (2019) |
| Lilly USA, LLC | $8,330 | 24 | $0 (2024) |
| Amgen Inc. | $8,088 | 43 | $0 (2024) |
| Novo Nordisk Inc | $6,063 | 31 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $3,346 | 16 | $0 (2024) |
| IBSA Pharma Inc. | $2,138 | 13 | $0 (2024) |
| Corcept Therapeutics | $871.52 | 32 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $676.01 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $598.96 | 26 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,485 | 47 | Amgen Inc. ($7,476) |
| 2023 | $20,417 | 92 | Horizon Therapeutics plc ($19,266) |
| 2022 | $2,822 | 35 | Novo Nordisk Inc ($2,058) |
| 2021 | $1,124 | 33 | IBSA Pharma Inc. ($500.00) |
| 2020 | $1,913 | 25 | IBSA Pharma Inc. ($1,559) |
| 2019 | $1,059 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($284.82) |
| 2018 | $4,792 | 67 | Novo Nordisk Inc ($3,530) |
| 2017 | $24,067 | 110 | Shire North American Group Inc ($11,133) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Oncology | ||||||
| 11/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $47.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | Eisai Inc. | — | Food and Beverage | In-kind items and services | $32.02 | General |
| 10/31/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $76.73 | General |
| 10/24/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Rare Disease | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: LIVER DISEASE | ||||||
| 10/03/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $560.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/26/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Endocrinology | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $280.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Endocrinology | ||||||
| 06/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,245 | 5,362 | $349,022 | $113,132 |
| 2022 | 35 | 2,431 | 5,510 | $365,893 | $113,942 |
| 2021 | 34 | 2,652 | 5,986 | $393,758 | $127,433 |
| 2020 | 32 | 2,664 | 5,688 | $371,634 | $110,285 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 6 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82533 | Cortisol (hormone) measurement | Office | 2020 | 21 | 25 | $1,125 | $375.59 | 33.4% |
| 84146 | Prolactin (milk producing hormone) level | Office | 2020 | 11 | 18 | $900.00 | $330.30 | 36.7% |
| 81000 | Manual urinalysis test with examination using microscope | Office | 2020 | 62 | 84 | $1,260 | $326.04 | 25.9% |
| 83525 | Insulin measurement | Office | 2020 | 19 | 29 | $1,334 | $313.65 | 23.5% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 12 | 23 | $1,265 | $311.60 | 24.6% |
| 86800 | Thyroglobulin (thyroid protein) antibody measurement | Office | 2020 | 14 | 18 | $1,134 | $283.82 | 25.0% |
| 86376 | Microsomal antibodies (autoantibody) measurement | Office | 2020 | 19 | 19 | $1,102 | $274.71 | 24.9% |
| 83540 | Iron level | Office | 2020 | 18 | 38 | $1,026 | $244.56 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 56 | 66 | $792.00 | $146.25 | 18.5% |
About Dr. Malini Gupta, M.D
Dr. Malini Gupta, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164626248.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malini Gupta, M.D has received a total of $64,680 in payments from pharmaceutical and medical device companies, with $8,485 received in 2024. These payments were reported across 465 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,300).
As a Medicare-enrolled provider, Gupta has provided services to 9,992 Medicare beneficiaries, totaling 22,546 services with total Medicare billing of $464,791. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Memphis, TN
- Active Since 06/13/2007
- Last Updated 08/05/2016
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164626248
Products in Payments
- TEPEZZA (Drug) $19,505
- NATPARA (Drug) $11,170
- BASAGLAR (Drug) $6,838
- TEPEZZA (Biological) $6,636
- Victoza (Drug) $3,482
- Strensiq (Drug) $3,309
- Tirosint (Drug) $2,163
- Rybelsus (Drug) $2,040
- Korlym (Drug) $871.52
- FARXIGA (Drug) $579.97
- Repatha (Biological) $458.95
- TOUJEO (Drug) $451.95
- JARDIANCE (Drug) $323.60
- CYCLOSET (Drug) $314.84
- SYNTHROID (Drug) $300.61
- Ozempic (Drug) $237.37
- PRALUENT ALIROCUMAB INJECTION (Biological) $211.37
- Tymlos (Biological) $189.10
- MYCAPSSA (Drug) $141.87
- MYALEPT (Drug) $127.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Memphis
Alan Cohen, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.8M
Dr. Shimon Harary, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $791,290
Dr. Samuel Dagogo-Jack, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $621,268
Dr. Aidar Gosmanov, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $314,600
Dr. Maher Ghawji, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $15,733
Fariha Salman
Endocrinology, Diabetes & Metabolism — Payments: $14,392